David Charles Lubner
Director · 6 filings · Latest: Aug 5, 2026
Arcellx, Inc.
Braveheart Bio, Inc.
CRESCENT BIOPHARMA, INC.
Dyne Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BRVE | David Charles Lubner | Director | Aug 7, 2026 | Purchase | $18.00 | 55,555 | $1000.0K | 55,555 | |
ACLX | David Charles Lubner | Director | Jan 20, 2026 | Sale | $75.00 | 6,000 | $450.0K | 21,659 | |
ACLX | David Charles Lubner | Director | Jan 20, 2026 | Option Exercise | $6.28 | 6,000 | $37.7K | 27,659 | |
ACLX | DAVID LUBNER | — | Jan 20, 2026 | Proposed Sale | $68.94 | 15,000 | $1.0M | — |